Skip to main content
. 2001 Jun;51(6):541–546. doi: 10.1046/j.1365-2125.2001.01395.x

Figure 1.

Figure 1

Plasma concentration-time profile for dihydroartemisinin following 312 µmol i.v. artesunate (•), 391 µmol oral artesunate (○) or 422 µmol oral dihydroartemisinin (▵) in group 1 volunteers (a), group 2 volunteers (b) and group 3 patients (c). Data shown as mean±s.d.).